| 4001 | GSR levels | GCST90469410 | 2.47 |
| 4002 | HPGDS/ITGAV ratio | GCST90315080 | 2.47 |
| 4003 | 2s,3R-dihydroxybutyrate levels | GCST90199882 | 2.47 |
| 4004 | Concentration of large LDL particles | GCST90498037 | 2.47 |
| 4005 | Social and economic stability (confirmatory factor analysis Factor 15) | GCST90309349 | 2.47 |
| 4006 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486 | ECGA000486 | 2.47 |
| 4007 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 2.46 |
| 4008 | MTHFSD levels | GCST90469956 | 2.46 |
| 4009 | Right ventricular ejection fraction (MTAG) | GCST90134595 | 2.46 |
| 4010 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208 | ECGU000208 | 2.46 |
| 4011 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T150 | ECGA000150 | 2.46 |
| 4012 | Skin brightness | GCST90502777 | 2.46 |
| 4013 | aseg rh volume CerebralWhiteMatter | GCST90002632 | 2.45 |
| 4014 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T350 | ECGU000350 | 2.45 |
| 4015 | CTRB1/KIRREL2 ratio | GCST90314306 | 2.45 |
| 4016 | Myo-inositol levels | GCST90243527 | 2.45 |
| 4017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345 | ECGA000345 | 2.45 |
| 4018 | LGALS9 levels | GCST90469765 | 2.45 |
| 4019 | FADD/LACTB2 ratio | GCST90314767 | 2.45 |
| 4020 | Standing height (UKB data field 50) | GCST90468178 | 2.44 |
| 4021 | Alzheimer's disease (MTAG) | GCST90449060 | 2.44 |
| 4022 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181 | ECGA000181 | 2.44 |
| 4023 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 2.44 |
| 4024 | CPB1/REG1B ratio | GCST90314213 | 2.44 |
| 4025 | BA-exvivo lh thickness BA1 | GCST90003513 | 2.44 |
| 4026 | ENTPD5 levels | GCST90241024 | 2.44 |
| 4027 | MIF/PARK7 ratio | GCST90315447 | 2.44 |
| 4028 | SH2B3 levels | GCST90470616 | 2.44 |
| 4029 | T1 FreeSurfer pial rh posteriorcingulate area | GCST90385844 | 2.43 |
| 4030 | ANGPT1 levels | GCST90468300 | 2.43 |
| 4031 | ASGR1/GGT5 ratio | GCST90313365 | 2.43 |
| 4032 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 2.43 |
| 4033 | Cholesteryl ester_18:1_[M+NH4]1+ levels | GCST90060221 | 2.43 |
| 4034 | BA-exvivo lh area V2 | GCST90003217 | 2.43 |
| 4035 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T32 | ECGA000032 | 2.43 |
| 4036 | aparc-DKTatlas rh thickness postcentral | GCST90003591 | 2.43 |
| 4037 | Hallux rigidus | FING00000600 | 2.42 |
| 4038 | Cholesteryl esters in IDL (UKB data field 23527) | GCST90269624 | 2.42 |
| 4039 | Total phospholipid levels in lipoprotein particles | GCST90092991 | 2.42 |
| 4040 | rfMRI amplitudes (ICA100 node 38) | GCST90004626 | 2.42 |
| 4041 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174 | ECGU000174 | 2.42 |
| 4042 | TBCB levels | GCST90470813 | 2.42 |
| 4043 | Clinical LDL cholesterol levels (UKB data field 23404) | GCST90269501 | 2.42 |
| 4044 | PTPRB levels | GCST90470379 | 2.42 |
| 4045 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491 | ECGA000491 | 2.42 |
| 4046 | Omega-3 fatty acid levels | GCST90502441 | 2.41 |
| 4047 | Total lipids in small LDL | GCST90499656 | 2.41 |
| 4048 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 2.41 |
| 4049 | Body fat percentage | Impedance measures | UKBB00000102 | 2.41 |
| 4050 | ANXA4/FADD ratio | GCST90313291 | 2.41 |
| 4051 | ARSB levels | GCST90468369 | 2.41 |
| 4052 | Triglyceride to phosphoglyceride ratio | GCST90454483 | 2.41 |
| 4053 | Cheesecake liking | GCST90094730 | 2.41 |
| 4054 | SYTL4 levels | GCST90470795 | 2.41 |
| 4055 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T130 | ECGA000130 | 2.41 |
| 4056 | PTPRN2/RTBDN ratio | GCST90315754 | 2.41 |
| 4057 | SKAP2/VSIR ratio | GCST90315849 | 2.40 |
| 4058 | Total lipids in IDL (UKB data field 23524) | GCST90269621 | 2.40 |
| 4059 | Hereditary and idiopathic peripheral neuropathy (PheCode 356) | GCST90475844 | 2.40 |
| 4060 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T347 | ECGU000347 | 2.40 |
| 4061 | Fasting plasma glucose | GCST90566420 | 2.40 |
| 4062 | TREM2 levels | GCST90470960 | 2.40 |
| 4063 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T320 | ECGU000320 | 2.40 |
| 4064 | AGRN/CRIM1 ratio | GCST90313200 | 2.40 |
| 4065 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 2.40 |
| 4066 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66 | ECGU000066 | 2.40 |
| 4067 | SERPINI2 levels | GCST90470603 | 2.40 |
| 4068 | ESYT2 levels | GCST90469156 | 2.40 |
| 4069 | Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | Medication | UKBB00000455 | 2.40 |
| 4070 | ThalamNuclei rh volume CM | GCST90002742 | 2.40 |
| 4071 | INHBC levels | GCST90469615 | 2.40 |
| 4072 | MSR1 levels | GCST90469950 | 2.40 |
| 4073 | Fibrosis and cirrhosis of liver | FING00000543 | 2.40 |
| 4074 | Atherosclerosis (PheCode 440) | GCST90475989 | 2.39 |
| 4075 | FKBP1B/PRDX5 ratio | GCST90314833 | 2.39 |
| 4076 | Cirrhosis | GCST90018606 | 2.39 |
| 4077 | HNMT levels | GCST90469468 | 2.39 |
| 4078 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 2.39 |
| 4079 | AP3B1 levels | GCST90468325 | 2.39 |
| 4080 | FGD3 levels | GCST90469217 | 2.39 |
| 4081 | GMPR levels | GCST90469368 | 2.39 |
| 4082 | TNFRSF4/TNFRSF8 ratio | GCST90315938 | 2.39 |
| 4083 | Linoleic acid levels | GCST90502310 | 2.39 |
| 4084 | Frequency of tiredness / lethargy in last 2 weeks | Mental health | UKBB00000268 | 2.39 |
| 4085 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 2.38 |
| 4086 | ANXA4 levels | GCST90468319 | 2.38 |
| 4087 | SOD1 levels | GCST90470704 | 2.38 |
| 4088 | MAP3K5/ZBTB16 ratio | GCST90315380 | 2.38 |
| 4089 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251 | ECGU000251 | 2.38 |
| 4090 | Effects radiation NOS (PheCode 990) | GCST90476293 | 2.38 |
| 4091 | Irritable bowel syndrome | GCST90243958 | 2.38 |
| 4092 | Lupus erythematosus | FING00000739 | 2.38 |
| 4093 | IDP dMRI TBSS FA Anterior limb of internal capsule R | GCST90003893 | 2.38 |
| 4094 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 100) | GCST90320919 | 2.37 |
| 4095 | AIDA levels | GCST90468265 | 2.37 |
| 4096 | Total lipid levels in lipoprotein particles | GCST90092989 | 2.37 |
| 4097 | Benign neoplasm: Colon, unspecified | FING00000172 | 2.37 |
| 4098 | KLB levels | GCST90469693 | 2.37 |
| 4099 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 2.37 |
| 4100 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T348 | ECGU000348 | 2.36 |
| 4101 | BCAT1 levels | GCST90468427 | 2.36 |
| 4102 | Type 2 diabetes, definitions combined | FING00001382 | 2.36 |
| 4103 | CD244/CRTAM ratio | GCST90313763 | 2.36 |
| 4104 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502596 | 2.36 |
| 4105 | Platelet count | GCST90018749 | 2.36 |
| 4106 | Type 2 diabetes | GCST005413 | 2.36 |
| 4107 | CPB1 levels | GCST90468839 | 2.36 |
| 4108 | DLK1/PIK3IP1 ratio | GCST90314492 | 2.36 |
| 4109 | CA4/PECAM1 ratio | GCST90313586 | 2.36 |
| 4110 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90025427 | 2.36 |
| 4111 | CD74 levels | GCST90468647 | 2.36 |
| 4112 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 2.36 |
| 4113 | Coronary atherosclerosis (PheCode 411.4) | GCST90475936 | 2.35 |
| 4114 | IDP dMRI ProbtrackX ISOVF str l | GCST90004548 | 2.35 |
| 4115 | Standing height | Body size measures | UKBB00000796 | 2.35 |
| 4116 | Hypopotassemia (PheCode 276.14) | GCST90475755 | 2.35 |
| 4117 | Cholesterol in medium VLDL (UKB data field 23505) | GCST90269602 | 2.35 |
| 4118 | Memory loss or impairment | GCST90475544 | 2.35 |
| 4119 | Smoking status (standard GWA) | GCST90267302 | 2.34 |
| 4120 | Substance abuse (more control exclusions) | FING00001341 | 2.34 |
| 4121 | STAT2 levels | GCST90470758 | 2.34 |
| 4122 | Depression or dysthymia | FING00000400 | 2.34 |
| 4123 | DTI autoptx MD ifo r tract | GCST90385233 | 2.34 |
| 4124 | CD40LG/MPIG6B ratio | GCST90313825 | 2.34 |
| 4125 | PAM levels | GCST90470156 | 2.34 |
| 4126 | CCN3/PGF ratio | GCST90313722 | 2.34 |
| 4127 | IDP T1 FIRST left putamen volume | GCST90002440 | 2.34 |
| 4128 | aparc-Desikan lh volume parsopercularis | GCST90002785 | 2.34 |
| 4129 | SSH3 levels | GCST90470749 | 2.33 |
| 4130 | IL1R1 levels | GCST90425563 | 2.33 |
| 4131 | 3-amino-2-piperidone levels | GCST90200188 | 2.33 |
| 4132 | DTI autoptx L2 ilf l tract | GCST90385180 | 2.33 |
| 4133 | CCN3/FAP ratio | GCST90313721 | 2.33 |
| 4134 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393 | ECGA000393 | 2.33 |
| 4135 | COL6A3/NBL1 ratio | GCST90314176 | 2.33 |
| 4136 | GNPDA2 levels | GCST90469374 | 2.33 |
| 4137 | ICAM5 levels | GCST90241541 | 2.33 |
| 4138 | Subarachnoid haemorrhage | FING00001339 | 2.32 |
| 4139 | Free androgen index | GCST90239823 | 2.32 |
| 4140 | UBXN1 levels | GCST90471004 | 2.32 |
| 4141 | Phospholipids in large LDL (UKB data field 23532) | GCST90269629 | 2.32 |
| 4142 | REST UKBBICA NET100 1111 | GCST90386965 | 2.32 |
| 4143 | CLIP2 levels | GCST90468782 | 2.32 |
| 4144 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 2.31 |
| 4145 | Acne (PheCode 706.1) | GCST90476211 | 2.31 |
| 4146 | Total lipid levels in IDL | GCST90092837 | 2.31 |
| 4147 | CALCOCO1/PDLIM7 ratio | GCST90313607 | 2.31 |
| 4148 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 2.31 |
| 4149 | SERPINE1/SMAD1 ratio | GCST90315833 | 2.31 |
| 4150 | PDGFC/TFPI ratio | GCST90315636 | 2.31 |
| 4151 | CTSO levels | GCST90179277 | 2.31 |
| 4152 | Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivity | GCST90302710 | 2.31 |
| 4153 | Omega-3 fatty acids to total fatty acids percentage | GCST90502090 | 2.31 |
| 4154 | IDP dMRI ProbtrackX L1 cgc l | GCST90004250 | 2.30 |
| 4155 | Abnormal heart sounds (PheCode 396) | GCST90475916 | 2.30 |
| 4156 | Abdominal hernia | digestive | UKBB00000002 | 2.30 |
| 4157 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 2.30 |
| 4158 | CRLF1 levels | GCST90468868 | 2.30 |
| 4159 | GDNF levels | GCST90274792 | 2.30 |
| 4160 | CD69/NFATC1 ratio | GCST90313879 | 2.30 |
| 4161 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 2.30 |
| 4162 | CDC37/PPP1R12A ratio | GCST90313934 | 2.30 |
| 4163 | MMP1/SERPINB6 ratio | GCST90315462 | 2.30 |
| 4164 | HBEGF/SDC4 ratio | GCST90315037 | 2.30 |
| 4165 | NUMB levels | GCST90470108 | 2.30 |
| 4166 | MINDY1 levels | GCST90469908 | 2.29 |
| 4167 | BAMBI levels | GCST90468420 | 2.29 |
| 4168 | Hematocrit | GCST004604 | 2.29 |
| 4169 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T416 | ECGU000416 | 2.29 |
| 4170 | Pulse rate | Arterial stiffness | UKBB00000722 | 2.29 |
| 4171 | Maximum indexed left atrial volume | GCST90019012 | 2.29 |
| 4172 | Total esterified cholesterol levels | GCST90092986 | 2.29 |
| 4173 | Medication use (vasodilators used in cardiac diseases) | GCST90018763 | 2.29 |
| 4174 | APP/FKBP1B ratio | GCST90313323 | 2.29 |
| 4175 | TPPP3 levels | GCST90470948 | 2.29 |
| 4176 | YES1 levels | GCST90471088 | 2.28 |
| 4177 | T1 FreeSurfer aseg lhCerebralWhiteMatterVol | GCST90384185 | 2.28 |
| 4178 | IDP T1 FAST ROIs L precentral gyrus | GCST90002463 | 2.28 |
| 4179 | IL22RA2 levels | GCST90090699 | 2.28 |
| 4180 | Cholesteryl ester levels in very small VLDL | GCST90093030 | 2.28 |
| 4181 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T148 | ECGA000148 | 2.28 |
| 4182 | N-formylmethionine levels | GCST90200343 | 2.28 |
| 4183 | IDP dMRI TBSS L3 Posterior thalamic radiation R | GCST90004199 | 2.28 |
| 4184 | Treatment speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000834 | 2.28 |
| 4185 | BCL2L11/RAB6A ratio | GCST90313484 | 2.28 |
| 4186 | JAM2 levels | GCST90469659 | 2.28 |
| 4187 | CALCOCO1/CRACR2A ratio | GCST90313598 | 2.28 |
| 4188 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341 | ECGU000341 | 2.27 |
| 4189 | LAYN levels | GCST90469742 | 2.27 |
| 4190 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343 | ECGA000343 | 2.27 |
| 4191 | GGH/INHBC ratio | GCST90314928 | 2.27 |
| 4192 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T345 | ECGU000345 | 2.27 |
| 4193 | CLEC1B/HEXIM1 ratio | GCST90314093 | 2.27 |
| 4194 | CD5/IL16 ratio | GCST90313861 | 2.26 |
| 4195 | F7/VASN ratio | GCST90314745 | 2.26 |
| 4196 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025683 | 2.26 |
| 4197 | RNF146 levels | GCST90421479 | 2.26 |
| 4198 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T311 | ECGA000311 | 2.26 |
| 4199 | X-18922 levels | GCST90200578 | 2.26 |
| 4200 | RNF41 levels | GCST90470485 | 2.26 |
| 4201 | CDON/SCARA5 ratio | GCST90313995 | 2.25 |
| 4202 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T333 | ECGU000333 | 2.25 |
| 4203 | SFTPD levels | GCST90470614 | 2.25 |
| 4204 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379 | ECGU000379 | 2.25 |
| 4205 | CLEC4G/NELL2 ratio | GCST90314122 | 2.25 |
| 4206 | aparc-Desikan rh thickness postcentral | GCST90003500 | 2.25 |
| 4207 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T147 | ECGA000147 | 2.25 |
| 4208 | CLSTN3 levels | GCST90468790 | 2.25 |
| 4209 | Triacylglycerol_51:4_[M+NH4]1+ levels | GCST90060491 | 2.25 |
| 4210 | DKK1/MGLL ratio | GCST90314473 | 2.25 |
| 4211 | STXBP1 levels | GCST90470777 | 2.24 |
| 4212 | PCDH1 levels | GCST90470170 | 2.24 |
| 4213 | IDP dMRI ProbtrackX ICVF ptr r | GCST90004395 | 2.24 |
| 4214 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T357 | ECGU000357 | 2.24 |
| 4215 | Diacylglycerol_32:2_[M+H-H2O]1+ levels | GCST90060168 | 2.24 |
| 4216 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T330 | ECGA000330 | 2.24 |
| 4217 | BID levels | GCST90468444 | 2.24 |
| 4218 | Other abnormal uterine and vaginal bleeding | FING00000919 | 2.24 |
| 4219 | NEO1 levels | GCST90470029 | 2.24 |
| 4220 | Heart rate variability (standard deviation of normal-to-normal intervals) | GCST90281265 | 2.23 |
| 4221 | ALCAM/CDH5 ratio | GCST90313234 | 2.23 |
| 4222 | F-savour/caloric food liking (derived food-liking factor) | GCST90094835 | 2.23 |
| 4223 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498852 | 2.23 |
| 4224 | DSG2 levels | GCST90469042 | 2.22 |
| 4225 | CDH2/CDHR2 ratio | GCST90313950 | 2.22 |
| 4226 | Triglycerides | GCST90018755 | 2.22 |
| 4227 | ALCAM/LRRC25 ratio | GCST90313239 | 2.22 |
| 4228 | DDX58 levels | GCST90468977 | 2.22 |
| 4229 | Neutrophil count | GCST90002351 | 2.22 |
| 4230 | CD84/SORT1 ratio | GCST90313918 | 2.22 |
| 4231 | NT5C3A/PRDX5 ratio | GCST90315567 | 2.22 |
| 4232 | aparc-Desikan lh area rostralmiddlefrontal | GCST90003099 | 2.22 |
| 4233 | CLEC1B/RWDD1 ratio | GCST90314102 | 2.22 |
| 4234 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495 | ECGA000495 | 2.22 |
| 4235 | PDLIM7/TBC1D23 ratio | GCST90315640 | 2.21 |
| 4236 | BIN2/EREG ratio | GCST90313503 | 2.21 |
| 4237 | CD163 levels | GCST90468600 | 2.21 |
| 4238 | PECAM1/SOD2 ratio | GCST90315647 | 2.21 |
| 4239 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123 | ECGU000123 | 2.21 |
| 4240 | Eye problems/disorders - Cataract | Eyesight | UKBB00000230 | 2.21 |
| 4241 | Blood urea nitrogen levels | GCST90278623 | 2.21 |
| 4242 | Statin medication | FING00001331 | 2.21 |
| 4243 | PBLD levels | GCST90470163 | 2.21 |
| 4244 | Volume of left lateral nucleus | GCST90474973 | 2.21 |
| 4245 | CST3/DEFA1_DEFA1B ratio | GCST90314291 | 2.20 |
| 4246 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T161 | ECGA000161 | 2.20 |
| 4247 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353 | ECGU000353 | 2.20 |
| 4248 | DOK2/SNX9 ratio | GCST90314539 | 2.20 |
| 4249 | HEXIM1/NUB1 ratio | GCST90315049 | 2.20 |
| 4250 | PLA2G4A levels | GCST90470248 | 2.20 |
| 4251 | Other disorders of eyelids (PheCode 374) | GCST90475890 | 2.20 |
| 4252 | TGFBI/VASN ratio | GCST90315915 | 2.20 |
| 4253 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 2.19 |
| 4254 | Retinal arteriolar tortuosity | GCST90270397 | 2.19 |
| 4255 | IL13RA1 levels | GCST90469552 | 2.19 |
| 4256 | ST13 levels | GCST90470751 | 2.19 |
| 4257 | NPTX2 levels | GCST90470079 | 2.19 |
| 4258 | Sum neutrophil eosinophil counts | GCST004613 | 2.19 |
| 4259 | F7 levels | GCST90469171 | 2.19 |
| 4260 | IDP dMRI ProbtrackX ISOVF ifo l | GCST90004537 | 2.18 |
| 4261 | Mean bone marrow fat fraction of left and right proximal femur | GCST90652394 | 2.18 |
| 4262 | HippSubfield rh volume subiculum-head | GCST90002693 | 2.18 |
| 4263 | CPQ levels | GCST90468846 | 2.18 |
| 4264 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177 | ECGA000177 | 2.18 |
| 4265 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | GCST90092984 | 2.18 |
| 4266 | Height decline (log-difference score) | GCST90565853 | 2.18 |
| 4267 | SUSD5 levels | GCST90470789 | 2.18 |
| 4268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T352 | ECGA000352 | 2.18 |
| 4269 | RRM2B levels | GCST90470500 | 2.17 |
| 4270 | GPNMB levels | GCST90469393 | 2.17 |
| 4271 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 2.17 |
| 4272 | GRSF1 levels | GCST90469407 | 2.17 |
| 4273 | ADGRG1 levels | GCST90468240 | 2.17 |
| 4274 | ALB levels | GCST90269576 | 2.17 |
| 4275 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 2.17 |
| 4276 | Rectal cancer | GCST90011810 | 2.17 |
| 4277 | Calcific aortic valve stenosis | GCST90310293 | 2.17 |
| 4278 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T351 | ECGU000351 | 2.17 |
| 4279 | NUDT16 levels | GCST90470105 | 2.16 |
| 4280 | Prescriptions - beta2-agonist|bronchodilator|asthma | UKBB00000670 | 2.16 |
| 4281 | Prescriptions - albuterol | beta2-agonist,bronchodilator,asthma | UKBB00000658 | 2.16 |
| 4282 | IDP dMRI TBSS ICVF Medial lemniscus L | GCST90004336 | 2.16 |
| 4283 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 2.16 |
| 4284 | Propionylglycine levels | GCST90199705 | 2.16 |
| 4285 | triglyceride (maximum, inv-norm transformed) | GCST90476429 | 2.16 |
| 4286 | GCG levels | GCST90469316 | 2.16 |
| 4287 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68 | ECGU000068 | 2.16 |
| 4288 | ERBB4/NELL1 ratio | GCST90314691 | 2.16 |
| 4289 | Ever had period extreme irritability | Mania | UKBB00000217 | 2.16 |
| 4290 | TFF1/TFF2 ratio | GCST90315914 | 2.16 |
| 4291 | HEG1 levels | GCST90469444 | 2.15 |
| 4292 | PRCP levels | GCST90470314 | 2.15 |
| 4293 | GFRA3 levels | GCST90469330 | 2.15 |
| 4294 | CCL11/CCL7 ratio | GCST90313673 | 2.15 |
| 4295 | Coagulation defects (PheCode 286) | GCST90475796 | 2.15 |
| 4296 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T299 | ECGU000299 | 2.14 |
| 4297 | CCS levels | GCST90468594 | 2.14 |
| 4298 | EFNA4/VWC2 ratio | GCST90314607 | 2.14 |
| 4299 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T349 | ECGU000349 | 2.14 |
| 4300 | CRTAM/TNFRSF9 ratio | GCST90314280 | 2.14 |
| 4301 | DTYMK levels | GCST90469049 | 2.14 |
| 4302 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203 | ECGU000203 | 2.14 |
| 4303 | PTPRK levels | GCST90470383 | 2.14 |
| 4304 | TNFRSF14 levels | GCST90470907 | 2.14 |
| 4305 | Triacylglycerol_53:4_[M+NH4]1+ levels | GCST90060524 | 2.14 |
| 4306 | Gallstone disease | GCST90128518 | 2.14 |
| 4307 | EGF/MPIG6B ratio | GCST90314611 | 2.13 |
| 4308 | STK24 levels | GCST90470766 | 2.13 |
| 4309 | Takes medication for heart attack? | GCST90475212 | 2.13 |
| 4310 | Alzheimer's disease | GCST90027158 | 2.13 |
| 4311 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 2.13 |
| 4312 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T196 | ECGU000196 | 2.13 |
| 4313 | Concentration of large LDL particles | GCST90498029 | 2.13 |
| 4314 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 2.13 |
| 4315 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 2.13 |
| 4316 | Trunk fat mass | Impedance measures | UKBB00000863 | 2.12 |
| 4317 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469 | ECGU000469 | 2.12 |
| 4318 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121 | ECGA000121 | 2.12 |
| 4319 | EEF1D levels | GCST90469075 | 2.12 |
| 4320 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498847 | 2.12 |
| 4321 | LAMP3/PRSS8 ratio | GCST90315275 | 2.12 |
| 4322 | FKBP1B/TGFB1 ratio | GCST90314836 | 2.12 |
| 4323 | DLL1/TGFBR2 ratio | GCST90314499 | 2.12 |
| 4324 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T328 | ECGA000328 | 2.12 |
| 4325 | RHOC levels | GCST90470467 | 2.12 |
| 4326 | IDP SWI T2star left caudate | GCST90003865 | 2.12 |
| 4327 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 2.11 |
| 4328 | Wears glasses or contact lenses (UKB data field 2207) | GCST90042875 | 2.11 |
| 4329 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 2.11 |
| 4330 | DSG3/DSG4 ratio | GCST90314558 | 2.11 |
| 4331 | ICAM1/REG1A ratio | GCST90315114 | 2.11 |
| 4332 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499564 | 2.11 |
| 4333 | LDL cholesterol levels (UKB data field 23405) | GCST90269502 | 2.11 |
| 4334 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T103 | ECGA000103 | 2.11 |
| 4335 | GRAP2 levels | GCST90469399 | 2.11 |
| 4336 | ThalamNuclei lh volume VLp | GCST90002734 | 2.11 |
| 4337 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119 | ECGA000119 | 2.11 |
| 4338 | PLAUR/PRSS8 ratio | GCST90315675 | 2.11 |
| 4339 | FKBP4/RWDD1 ratio | GCST90314840 | 2.11 |
| 4340 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114 | ECGU000114 | 2.11 |
| 4341 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 2.11 |
| 4342 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T204 | ECGU000204 | 2.10 |
| 4343 | RTN4R levels | GCST90470508 | 2.10 |
| 4344 | EREG/TIMP3 ratio | GCST90314708 | 2.10 |
| 4345 | Other mental disorder | mental disorders | UKBB00000614 | 2.10 |
| 4346 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T253 | ECGA000253 | 2.10 |
| 4347 | DTI autoptx MD ifo l tract | GCST90385232 | 2.10 |
| 4348 | CKAP4/TNFRSF4 ratio | GCST90314076 | 2.10 |
| 4349 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 2.10 |
| 4350 | Sum basophil neutrophil counts | GCST004620 | 2.09 |
| 4351 | GRAP2/PPP1R2 ratio | GCST90314985 | 2.09 |
| 4352 | BCAM/CDH5 ratio | GCST90313469 | 2.09 |
| 4353 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227 | ECGU000227 | 2.09 |
| 4354 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T336 | ECGA000336 | 2.09 |
| 4355 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 88) | GCST90320907 | 2.09 |
| 4356 | Hemoglobin concentration | GCST90002310 | 2.09 |
| 4357 | CD300C/MANSC1 ratio | GCST90313791 | 2.09 |
| 4358 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T124 | ECGU000124 | 2.09 |
| 4359 | Sporadic miscarriage | GCST011888 | 2.09 |
| 4360 | PSAP levels | GCST90426586 | 2.09 |
| 4361 | DAG1 levels | GCST90468943 | 2.09 |
| 4362 | ST6GALNAC2 levels | GCST90240251 | 2.08 |
| 4363 | Aplastic anemia (PheCode 284) | GCST90475783 | 2.08 |
| 4364 | DTI autoptx L3 cgc r tract | GCST90385198 | 2.08 |
| 4365 | IDP dMRI TBSS L1 Genu of corpus callosum | GCST90004077 | 2.08 |
| 4366 | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302693 | 2.08 |
| 4367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T354 | ECGU000354 | 2.08 |
| 4368 | End-diastolic bi-ventricular shape (principal component 4) | GCST90448483 | 2.07 |
| 4369 | Hepatic cancer | GCST90018638 | 2.07 |
| 4370 | JAM2/TNFRSF21 ratio | GCST90315242 | 2.07 |
| 4371 | BACH1/SNAP23 ratio | GCST90313446 | 2.07 |
| 4372 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T329 | ECGA000329 | 2.07 |
| 4373 | Birth weight known - No | Early life factors | UKBB00000096 | 2.07 |
| 4374 | DTI TBSS L2 Fornix | GCST90384481 | 2.07 |
| 4375 | CANT1/NUDT5 ratio | GCST90313619 | 2.07 |
| 4376 | Cholesteryl ester_18:0_[M+NH4]1+ levels | GCST90060222 | 2.07 |
| 4377 | CNDP1 levels | GCST90468796 | 2.07 |
| 4378 | CCN1 levels | GCST90468587 | 2.07 |
| 4379 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 2.06 |
| 4380 | LDLR levels | GCST90469750 | 2.06 |
| 4381 | CA5A/GSTA1 ratio | GCST90313591 | 2.06 |
| 4382 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | GCST90004362 | 2.06 |
| 4383 | Average weekly beer plus cider intake | Alcohol | UKBB00000082 | 2.06 |
| 4384 | KLK11 levels | GCST90469697 | 2.06 |
| 4385 | HARS1 levels | GCST90469430 | 2.05 |
| 4386 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T157 | ECGA000157 | 2.05 |
| 4387 | CTSL levels | GCST90468914 | 2.05 |
| 4388 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 2.05 |
| 4389 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 2.05 |
| 4390 | Red blood cell (erythrocyte) count | Blood count | UKBB00000747 | 2.05 |
| 4391 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T301 | ECGU000301 | 2.04 |
| 4392 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T352 | ECGU000352 | 2.04 |
| 4393 | AKT1S1/TDRKH ratio | GCST90313233 | 2.04 |
| 4394 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202 | ECGU000202 | 2.04 |
| 4395 | aseg lh volume Cerebellum-Cortex | GCST90002619 | 2.04 |
| 4396 | Alzheimer's disease or family history of Alzheimer's disease | GCST007320 | 2.04 |
| 4397 | WFIKKN2 levels | GCST90471077 | 2.03 |
| 4398 | PDGFA/PRSS27 ratio | GCST90315616 | 2.03 |
| 4399 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320639 | 2.03 |
| 4400 | SLC27A4/TDRKH ratio | GCST90315851 | 2.03 |
| 4401 | CEBPB/NADK ratio | GCST90314006 | 2.03 |
| 4402 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T387 | ECGU000387 | 2.03 |
| 4403 | F-low caloric food liking (derived food-liking factor) | GCST90094795 | 2.03 |
| 4404 | IDP T1 FAST ROIs R hippocampus | GCST90002556 | 2.03 |
| 4405 | FGFR2/TGFBR2 ratio | GCST90314813 | 2.02 |
| 4406 | SIGLEC8 levels | GCST90470636 | 2.02 |
| 4407 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 2.02 |
| 4408 | Flavonifractor sp002159265 abundance in stool | GCST90032400 | 2.02 |
| 4409 | Trans-2-hexenoylglycine metabolite level | GCST90616136 | 2.02 |
| 4410 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 2.01 |
| 4411 | LEPR/NTRK2 ratio | GCST90315313 | 2.01 |
| 4412 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T331 | ECGA000331 | 2.01 |
| 4413 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 2.01 |
| 4414 | BA-exvivo rh volume BA4p | GCST90002854 | 2.01 |
| 4415 | CCL2/CCL7 ratio | GCST90313696 | 2.00 |
| 4416 | IDP T1 FAST ROIs L occ pole | GCST90002545 | 2.00 |
| 4417 | CD84/DAG1 ratio | GCST90313910 | 2.00 |
| 4418 | Duration of moderate activity | Physical activity | UKBB00000197 | 2.00 |
| 4419 | Height | GCST90025949 | 2.00 |
| 4420 | CLEC14A/TNFRSF21 ratio | GCST90314082 | 2.00 |
| 4421 | Height (baseline) | GCST90565843 | 2.00 |
| 4422 | SELL levels | GCST90470567 | 2.00 |
| 4423 | IDP dMRI TBSS ISOVF External capsule L | GCST90004510 | 2.00 |
| 4424 | HGS levels | GCST90469450 | 2.00 |
| 4425 | Height | GCST90302890 | 2.00 |
| 4426 | ADGRE5 levels | GCST90468238 | 1.99 |
| 4427 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104 | ECGU000104 | 1.99 |
| 4428 | MSR1/TNFRSF21 ratio | GCST90315494 | 1.99 |
| 4429 | SLC9A3R2 levels | GCST90470666 | 1.99 |
| 4430 | CA13 levels | GCST90468508 | 1.99 |
| 4431 | EREG/GYS1 ratio | GCST90314701 | 1.99 |
| 4432 | IDP dMRI ProbtrackX L2 cgc l | GCST90004277 | 1.98 |
| 4433 | Cholesterol levels in medium VLDL | GCST90092916 | 1.98 |
| 4434 | CNP levels | GCST90468798 | 1.98 |
| 4435 | Sphingomyelins levels (UKB data field 23438) | GCST90269535 | 1.98 |
| 4436 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 1.98 |
| 4437 | TNFRSF1A levels | GCST90470910 | 1.98 |
| 4438 | F2R/MPIG6B ratio | GCST90314732 | 1.98 |
| 4439 | FHIT levels | GCST90469238 | 1.98 |
| 4440 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 1.98 |
| 4441 | SUSD1 levels | GCST90470786 | 1.98 |
| 4442 | COX5B/GFER ratio | GCST90314200 | 1.97 |
| 4443 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 1.97 |
| 4444 | IDP dMRI ProbtrackX L2 str r | GCST90004297 | 1.97 |
| 4445 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346 | ECGA000346 | 1.97 |
| 4446 | Meniscus derangement | FING00000807 | 1.97 |
| 4447 | ENPP6 levels | GCST90469117 | 1.97 |
| 4448 | Umbilical hernia | digestive | UKBB00000880 | 1.97 |
| 4449 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T201 | ECGU000201 | 1.97 |
| 4450 | CD300LG levels | GCST90468623 | 1.97 |
| 4451 | PADI2 levels | GCST90470142 | 1.97 |
| 4452 | BBQ/grilled meat liking | GCST90094698 | 1.97 |
| 4453 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T351 | ECGA000351 | 1.97 |
| 4454 | APOB levels | GCST90497130 | 1.96 |
| 4455 | DTI autoptx L2 ifo r tract | GCST90385179 | 1.96 |
| 4456 | MPO levels | GCST90469937 | 1.96 |
| 4457 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 1.96 |
| 4458 | Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary Operations | UKBB00000571 | 1.96 |
| 4459 | Ventral hernia (PheCode 550.5) | GCST90476063 | 1.96 |
| 4460 | Deviated nasal septum | FING00000409 | 1.96 |
| 4461 | AK2 levels | GCST90468270 | 1.96 |
| 4462 | CLEC1B/DIABLO ratio | GCST90314087 | 1.96 |
| 4463 | Physical function (baseline) | GCST90565837 | 1.95 |
| 4464 | Endometrial cancer | GCST006464 | 1.95 |
| 4465 | IDP dMRI ProbtrackX ICVF ifo r | GCST90004388 | 1.95 |
| 4466 | Abdominal fat ratio | GCST90267360 | 1.95 |
| 4467 | CD300C/FOLR2 ratio | GCST90313787 | 1.95 |
| 4468 | GFRA3/LAYN ratio | GCST90314926 | 1.95 |
| 4469 | IRAK1 levels | GCST90469627 | 1.95 |
| 4470 | aparc-Desikan rh volume supramarginal | GCST90002831 | 1.95 |
| 4471 | Diverticulosis | digestive | UKBB00000190 | 1.95 |
| 4472 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T160 | ECGA000160 | 1.95 |
| 4473 | AZU1 levels | GCST90468408 | 1.95 |
| 4474 | Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivity | GCST90302672 | 1.95 |
| 4475 | SIGLEC7 levels | GCST90470635 | 1.95 |
| 4476 | CLEC4D/CLEC6A ratio | GCST90314109 | 1.95 |
| 4477 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 1.94 |
| 4478 | Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivity | GCST90302698 | 1.94 |
| 4479 | Saturated fatty acids to total fatty acids percentage | GCST90502701 | 1.94 |
| 4480 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 1.94 |
| 4481 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 1.94 |
| 4482 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | GCST90004214 | 1.94 |
| 4483 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 1.94 |
| 4484 | Triacylglycerol (52:4) [NL-16:0] levels | GCST90025170 | 1.94 |
| 4485 | CHI3L1/PRSS8 ratio | GCST90314044 | 1.94 |
| 4486 | Other hammer toe(s) (acquired) | FING00001054 | 1.94 |
| 4487 | Ulcer of lower limb, not elsewhere classified | FING00001385 | 1.94 |
| 4488 | Type 2 diabetes with neurological manifestations (PheCode 250.24) | GCST90475676 | 1.94 |
| 4489 | GPC1 levels | GCST90469386 | 1.94 |
| 4490 | LTBR/SIRPB1 ratio | GCST90315339 | 1.93 |
| 4491 | CCL23 levels | GCST90468575 | 1.93 |
| 4492 | TGFA levels | GCST90470842 | 1.93 |
| 4493 | Cholesterol | Blood biochemistry | UKBB00000134 | 1.93 |
| 4494 | Bipolar and major depression status - No Bipolar or Depression | Mental health | UKBB00000094 | 1.93 |
| 4495 | PDCD6 levels | GCST90470183 | 1.92 |
| 4496 | Wet age-related macular degeneration | FING00001448 | 1.92 |
| 4497 | rfMRI connectivity ICA-features 6 | GCST90006344 | 1.92 |
| 4498 | IDP dMRI ProbtrackX MD ar r | GCST90004220 | 1.92 |
| 4499 | Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302697 | 1.92 |
| 4500 | Birth weight known - Yes - pounds and ounces | Early life factors | UKBB00000097 | 1.92 |
| 4501 | LDL direct | Blood biochemistry | UKBB00000386 | 1.92 |
| 4502 | Diverticulosis and diverticulitis | digestive | UKBB00000191 | 1.92 |
| 4503 | IDP dMRI TBSS L3 Anterior limb of internal capsule R | GCST90004187 | 1.92 |
| 4504 | Sardines liking | GCST90094830 | 1.92 |
| 4505 | Left-hemisphere control network to caudate white-matter structural connectivity | GCST90302753 | 1.92 |
| 4506 | ARSA/CD164 ratio | GCST90313351 | 1.92 |
| 4507 | CLEC4G/KEL ratio | GCST90314119 | 1.91 |
| 4508 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199 | ECGU000199 | 1.91 |
| 4509 | QC T1 inverse SNR | GCST90006348 | 1.91 |
| 4510 | T1 FreeSurfer BA lh BA3a exvivo thickness | GCST90385521 | 1.91 |
| 4511 | MAP2K6 levels | GCST90469852 | 1.91 |
| 4512 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 1.91 |
| 4513 | Cholesteryl ester levels in large LDL | GCST90092858 | 1.91 |
| 4514 | SPINK4 levels | GCST90470723 | 1.91 |
| 4515 | Bone marrow fat fraction of thoracic vertebra 8 | GCST90652380 | 1.91 |
| 4516 | EDA2R levels | GCST90469067 | 1.91 |
| 4517 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T342 | ECGA000342 | 1.91 |
| 4518 | Arm fat percentage (right) | Impedance measures | UKBB00000046 | 1.91 |
| 4519 | PHOSPHO1 levels | GCST90470227 | 1.91 |
| 4520 | Microalbumin in urine | Urine assays | UKBB00000467 | 1.91 |
| 4521 | PROS1 levels | GCST90470337 | 1.90 |
| 4522 | CRTAM/LY9 ratio | GCST90314278 | 1.90 |
| 4523 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 1.90 |
| 4524 | PKLR/UBAC1 ratio | GCST90315660 | 1.90 |
| 4525 | Bladder stone | GCST90468116 | 1.90 |
| 4526 | Osteoporosis (PheCode 743.1) | GCST90476259 | 1.90 |
| 4527 | LDL cholesterol levels | GCST90092883 | 1.90 |
| 4528 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421 | ECGU000421 | 1.90 |
| 4529 | Valine levels | GCST90500176 | 1.90 |
| 4530 | MRAP levels | GCST90089910 | 1.90 |
| 4531 | DTI TBSS L2 Anterior limb of internal capsule R | GCST90384492 | 1.89 |
| 4532 | EDAR levels | GCST90425556 | 1.89 |
| 4533 | CD74/TIMD4 ratio | GCST90313896 | 1.89 |
| 4534 | NSFL1C/UBAC1 ratio | GCST90315565 | 1.89 |
| 4535 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279 | ECGA000279 | 1.89 |
| 4536 | T1 FreeSurfer pial rh lateraloccipital area | GCST90385832 | 1.89 |
| 4537 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T332 | ECGA000332 | 1.89 |
| 4538 | CA4/TGFBR2 ratio | GCST90313588 | 1.89 |
| 4539 | IL34 levels | GCST90469593 | 1.89 |
| 4540 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T321 | ECGU000321 | 1.89 |
| 4541 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 1.88 |
| 4542 | CHIT1 levels | GCST90468744 | 1.88 |
| 4543 | IDP dMRI TBSS L3 Cingulum hippocampus L | GCST90004208 | 1.88 |
| 4544 | Height decline (difference score) | GCST90565863 | 1.88 |
| 4545 | ThalamNuclei lh volume Whole-thalamus | GCST90002762 | 1.88 |
| 4546 | Plasma pregnenetriol sulfate* levels in chronic kidney disease | GCST90265866 | 1.88 |
| 4547 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000181 | 1.88 |
| 4548 | Docosahexaenoic acid levels | GCST90501986 | 1.88 |
| 4549 | FCER1A levels | GCST90469198 | 1.88 |
| 4550 | Volume of right lateral nucleus | GCST90475036 | 1.88 |
| 4551 | wg rh intensity-contrast parahippocampal | GCST90003842 | 1.88 |
| 4552 | Infantile hypertrophic pyloric stenosis | GCST006705 | 1.88 |
| 4553 | Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivity | GCST90302720 | 1.88 |
| 4554 | Triacylglycerol (50:0) [NL-18:0] levels | GCST90025151 | 1.87 |
| 4555 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T205 | ECGU000205 | 1.87 |
| 4556 | aparc-Desikan rh area supramarginal | GCST90003137 | 1.87 |
| 4557 | Hyperplasia of prostate | FING00000635 | 1.87 |
| 4558 | BA-exvivo rh area entorhinal | GCST90003234 | 1.87 |
| 4559 | Diacylglycerol_42:7_[M+H-H2O]1+ levels | GCST90060226 | 1.87 |
| 4560 | aparc-Desikan lh thickness GlobalMeanThickness | GCST90003445 | 1.87 |
| 4561 | Right ventricular ejection fraction | GCST90134591 | 1.87 |
| 4562 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93 | ECGA000093 | 1.87 |
| 4563 | Coronary revascularization (ANGIO or CABG) | FING00000360 | 1.86 |
| 4564 | Coffee difference liking | GCST90094738 | 1.86 |
| 4565 | SMAD1 levels | GCST90470675 | 1.86 |
| 4566 | NPY/SMOC1 ratio | GCST90315551 | 1.86 |
| 4567 | CLEC1B/MPIG6B ratio | GCST90314098 | 1.86 |
| 4568 | Citrate levels | GCST90243442 | 1.86 |
| 4569 | Concentration of LDL particles | GCST90498418 | 1.86 |
| 4570 | STX4 levels | GCST90470772 | 1.86 |
| 4571 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T250 | ECGA000250 | 1.86 |
| 4572 | Duration to complete alphanumeric path task (baseline) | GCST90565839 | 1.86 |
| 4573 | DTI autoptx L1 slf r tract | GCST90385161 | 1.86 |
| 4574 | rfMRI amplitudes (ICA100 node 30) | GCST90004618 | 1.86 |
| 4575 | Neutrophil count | GCST90002398 | 1.86 |
| 4576 | Getting up in morning | Sleep | UKBB00000285 | 1.86 |
| 4577 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T249 | ECGA000249 | 1.86 |
| 4578 | Pulmonary embolism | FING00001228 | 1.85 |
| 4579 | GYS1/PPP1R2 ratio | GCST90315001 | 1.85 |
| 4580 | NCS1/NPY ratio | GCST90315527 | 1.85 |
| 4581 | Hip minimal joint space width | GCST90281365 | 1.85 |
| 4582 | GPR37 levels | GCST90469397 | 1.85 |
| 4583 | IGF1 levels | GCST90468078 | 1.85 |
| 4584 | SNRPB2 levels | GCST90470697 | 1.85 |
| 4585 | TMED8 levels | GCST90470885 | 1.85 |
| 4586 | Rotator cuff injury | GCST90044700 | 1.85 |
| 4587 | Androsterone sulfate levels | GCST90200674 | 1.84 |
| 4588 | HS6ST1 levels | GCST90469479 | 1.84 |
| 4589 | Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels | GCST90060270 | 1.84 |
| 4590 | NOTCH1/SEMA7A ratio | GCST90315545 | 1.84 |
| 4591 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T248 | ECGA000248 | 1.84 |
| 4592 | MAN1A2 levels | GCST90469843 | 1.84 |
| 4593 | Reticulocyte percentage (UKB data field 30240) | GCST90468101 | 1.84 |
| 4594 | aparc-DKTatlas lh area fusiform | GCST90003239 | 1.84 |
| 4595 | Nap during day | Sleep | UKBB00000492 | 1.84 |
| 4596 | Diacylglycerol_44:6_[M+H-H2O]1+ levels | GCST90060245 | 1.83 |
| 4597 | MAX/TDRKH ratio | GCST90315406 | 1.83 |
| 4598 | LRRN1 levels | GCST90469806 | 1.83 |
| 4599 | OMD levels | GCST90470123 | 1.83 |
| 4600 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394 | ECGA000394 | 1.83 |
| 4601 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 1.83 |
| 4602 | PENK levels | GCST90470208 | 1.83 |
| 4603 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 1.83 |
| 4604 | XIAP levels | GCST90471083 | 1.83 |
| 4605 | Phospholipid levels in IDL | GCST90092839 | 1.83 |
| 4606 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 1.83 |
| 4607 | DTI TBSS MD Cingulum cingulate gyrus L | GCST90384607 | 1.82 |
| 4608 | RILP levels | GCST90470471 | 1.82 |
| 4609 | Leisure/social activities - Pub or social club | Social support | UKBB00000401 | 1.82 |
| 4610 | CDK8_CCNC levels | GCST90240825 | 1.82 |
| 4611 | rfMRI connectivity (ICA100 edge 619) | GCST90005472 | 1.82 |
| 4612 | Weight | GCST90018729 | 1.82 |
| 4613 | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302701 | 1.81 |
| 4614 | GP6 levels | GCST90469384 | 1.81 |
| 4615 | Left hippocampal volume (tail) | GCST90267951 | 1.81 |
| 4616 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 1.81 |
| 4617 | Mean corpuscular volume | GCST004602 | 1.81 |
| 4618 | CANT1 levels | GCST90468536 | 1.81 |
| 4619 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T193 | ECGU000193 | 1.81 |
| 4620 | IDP dMRI TBSS L2 External capsule R | GCST90004155 | 1.81 |
| 4621 | ICD10 N97.0: Female infertility associated with anovulation | GCST90454223 | 1.81 |
| 4622 | IDP T1 FAST ROIs V cerebellum VI | GCST90002567 | 1.81 |
| 4623 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246 | ECGA000246 | 1.81 |
| 4624 | CPB2 levels | GCST90468840 | 1.81 |
| 4625 | SNAP23/ZBTB16 ratio | GCST90315858 | 1.81 |
| 4626 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T198 | ECGU000198 | 1.80 |
| 4627 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T129 | ECGA000129 | 1.80 |
| 4628 | Total cholesterol minus HDL-C levels (UKB data field 23401) | GCST90269498 | 1.80 |
| 4629 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T200 | ECGU000200 | 1.80 |
| 4630 | CHI3L1/HSPG2 ratio | GCST90314043 | 1.80 |
| 4631 | Whole body fat mass | Impedance measures | UKBB00000914 | 1.80 |
| 4632 | Pulse rate, automated reading | Blood pressure | UKBB00000723 | 1.80 |
| 4633 | VNN2 levels | GCST90471044 | 1.80 |
| 4634 | Other chronic ischemic heart disease, unspecified | circulatory system | UKBB00000603 | 1.80 |
| 4635 | Haddock liking | GCST90094776 | 1.80 |
| 4636 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 1.79 |
| 4637 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T342 | ECGU000342 | 1.79 |
| 4638 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 1.79 |
| 4639 | DCTN6 levels | GCST90468960 | 1.79 |
| 4640 | TMSB10/ZBTB16 ratio | GCST90315926 | 1.79 |
| 4641 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T89 | ECGA000089 | 1.79 |
| 4642 | TMEM25 levels | GCST90470888 | 1.79 |
| 4643 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494 | ECGA000494 | 1.79 |
| 4644 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182 | ECGA000182 | 1.79 |
| 4645 | DTI TBSS MD Superior corona radiata L | GCST90384597 | 1.79 |
| 4646 | Height (standard GWA) | GCST90267284 | 1.79 |
| 4647 | Vaginitis/vulvovaginitis/vulvitis/abscess of vulva | FING00001412 | 1.79 |
| 4648 | NECTIN2/TNFRSF1A ratio | GCST90315532 | 1.79 |
| 4649 | TEK levels | GCST90012013 | 1.79 |
| 4650 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T195 | ECGU000195 | 1.78 |
| 4651 | HEPACAM2 levels | GCST90469445 | 1.78 |
| 4652 | SORT1/ST6GAL1 ratio | GCST90315869 | 1.78 |
| 4653 | NCK2 levels | GCST90470007 | 1.78 |
| 4654 | Ectropion or entropion (PheCode 374.1) | GCST90475891 | 1.78 |
| 4655 | ACVRL1/TNFRSF9 ratio | GCST90313160 | 1.78 |
| 4656 | TFRC levels | GCST90470840 | 1.78 |
| 4657 | RABGAP1L levels | GCST90470416 | 1.78 |
| 4658 | EIF4G1/PLA2G4A ratio | GCST90314638 | 1.78 |
| 4659 | NRCAM/NTRK2 ratio | GCST90315552 | 1.78 |
| 4660 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346 | ECGU000346 | 1.77 |
| 4661 | Redundant prepuce, phimosis and paraphimosis | FING00001246 | 1.77 |
| 4662 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189 | ECGU000189 | 1.77 |
| 4663 | RBM17 levels | GCST90470434 | 1.77 |
| 4664 | FUT8/TNFSF12 ratio | GCST90314894 | 1.77 |
| 4665 | Stearate 18:0 levels | GCST90243431 | 1.77 |
| 4666 | Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) | FING00000771 | 1.77 |
| 4667 | IDP dMRI TBSS L3 Posterior limb of internal capsule L | GCST90004190 | 1.77 |
| 4668 | IDP dMRI TBSS L2 Superior longitudinal fasciculus R | GCST90004163 | 1.77 |
| 4669 | Disorders of muscles | FING00000444 | 1.76 |
| 4670 | Other intervertebral disc disorders | FING00001063 | 1.76 |
| 4671 | Takes medication for coronary artery/ coronary heart disease? | GCST90475199 | 1.76 |
| 4672 | Gamma-CEHC levels | GCST90199864 | 1.76 |
| 4673 | Granulocyte count | GCST004614 | 1.76 |
| 4674 | Operation code - cholecystectomy/gall bladder removal | Operations | UKBB00000554 | 1.76 |
| 4675 | ACY1/SCLY ratio | GCST90313165 | 1.76 |
| 4676 | EFEMP1/IL18BP ratio | GCST90314596 | 1.76 |
| 4677 | Principal component-derived dietary pattern 11 | GCST90133016 | 1.76 |
| 4678 | ATRAID levels | GCST90468399 | 1.76 |
| 4679 | LIFR levels | GCST90469769 | 1.76 |
| 4680 | Ever taken cannabis | Cannabis use | UKBB00000224 | 1.75 |
| 4681 | METAP1D/PLXNA4 ratio | GCST90315427 | 1.75 |
| 4682 | HGF/TNFSF14 ratio | GCST90315060 | 1.75 |
| 4683 | Beer or cider consumption (glasses per month) (UKB data field 1578, 4420) | GCST90132988 | 1.75 |
| 4684 | NECTIN2/TNFRSF14 ratio | GCST90315531 | 1.75 |
| 4685 | IDP dMRI ProbtrackX FA ifo l | GCST90003937 | 1.75 |
| 4686 | Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI) | GCST003658 | 1.75 |
| 4687 | CDH5 levels | GCST90468676 | 1.75 |
| 4688 | Conductive hearing loss (PheCode 389.2) | GCST90475912 | 1.75 |
| 4689 | Gout, strict definition | FING00000588 | 1.75 |
| 4690 | CD93/CLEC14A ratio | GCST90313921 | 1.74 |
| 4691 | CCL14 levels | GCST90468566 | 1.74 |
| 4692 | KYNU/SCLY ratio | GCST90315265 | 1.74 |
| 4693 | sodium (minimum, inv-norm transformed) | GCST90476397 | 1.74 |
| 4694 | DTI autoptx FA ilf r tract | GCST90385127 | 1.74 |
| 4695 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 1.74 |
| 4696 | Cholesterol levels in very small VLDL | GCST90093028 | 1.74 |
| 4697 | Plasma 1-methylurate levels in chronic kidney disease | GCST90264240 | 1.74 |
| 4698 | FAM3B/FGF19 ratio | GCST90314776 | 1.74 |
| 4699 | NUCB2 levels | GCST90470101 | 1.74 |
| 4700 | CD163/IL18BP ratio | GCST90313736 | 1.74 |
| 4701 | PSME2 levels | GCST90470361 | 1.74 |
| 4702 | Coronary artery calcification | GCST90278456 | 1.73 |
| 4703 | ADAM12 levels | GCST90468216 | 1.73 |
| 4704 | 3-(4-hydroxyphenyl)lactate levels | GCST90243575 | 1.73 |
| 4705 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T251 | ECGA000251 | 1.73 |
| 4706 | Myeloid white cell count | GCST004626 | 1.73 |
| 4707 | Sebaceous cyst (PheCode 706.2) | GCST90476213 | 1.73 |
| 4708 | DTI autoptx MD slf l tract | GCST90385241 | 1.73 |
| 4709 | Total thigh muscle volume z-score | GCST90267356 | 1.73 |
| 4710 | Basophil percentage of white cells variance | GCST90565688 | 1.73 |
| 4711 | PLXNA4/USP8 ratio | GCST90315690 | 1.73 |
| 4712 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T316 | ECGU000316 | 1.73 |
| 4713 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 1.72 |
| 4714 | AXIN1/NFATC1 ratio | GCST90313415 | 1.72 |
| 4715 | Hearing difficulty problems background noise (UKB data field 2257) | GCST90042885 | 1.72 |
| 4716 | MANF/PRDX5 ratio | GCST90315365 | 1.72 |
| 4717 | aseg lh volume Cerebellum-White-Matter | GCST90002618 | 1.72 |
| 4718 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496 | ECGA000496 | 1.72 |
| 4719 | heart rate (HR, maximum, inv-normal transformed) | GCST90476334 | 1.72 |
| 4720 | Histidine levels | GCST90243404 | 1.72 |
| 4721 | RUVBL1 levels | GCST90470509 | 1.72 |
| 4722 | Lawsonibacter sp002161175 abundance in stool | GCST90032459 | 1.72 |
| 4723 | Alcohol dependence | FING00000050 | 1.72 |
| 4724 | Phospholipids in LDL | GCST90498432 | 1.72 |
| 4725 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333 | ECGA000333 | 1.71 |
| 4726 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T307 | ECGU000307 | 1.71 |
| 4727 | LEP levels | GCST90469757 | 1.71 |
| 4728 | Macular puckering of retina (PheCode 362.26) | GCST90475854 | 1.71 |
| 4729 | GMFG levels | GCST90469366 | 1.71 |
| 4730 | MYDGF levels | GCST90469972 | 1.71 |
| 4731 | CRACR2A levels | GCST90468853 | 1.71 |
| 4732 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 1.71 |
| 4733 | DIABLO levels | GCST90468994 | 1.71 |
| 4734 | MMP8/OLR1 ratio | GCST90315464 | 1.71 |
| 4735 | C5 levels | GCST90468500 | 1.70 |
| 4736 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475452 | 1.70 |
| 4737 | IRAG2/TBC1D23 ratio | GCST90315191 | 1.70 |
| 4738 | Kiwi liking | GCST90094788 | 1.70 |
| 4739 | Do you smoke now? | GCST90476389 | 1.70 |
| 4740 | Total protein levels | GCST90025995 | 1.70 |
| 4741 | aparc-DKTatlas lh area rostralmiddlefrontal | GCST90003259 | 1.70 |
| 4742 | VIT levels | GCST90471041 | 1.70 |
| 4743 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 1.70 |
| 4744 | PPP1R9B levels | GCST90470305 | 1.69 |
| 4745 | DTI TBSS MD Superior fronto-occipital fasciculus R | GCST90384614 | 1.69 |
| 4746 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T356 | ECGU000356 | 1.69 |
| 4747 | DTI TBSS MO Corticospinal tract R | GCST90384626 | 1.69 |
| 4748 | CSF1R levels | GCST90468880 | 1.69 |
| 4749 | PSAPL1 levels | GCST90242354 | 1.69 |
| 4750 | heart rate (HR, minimum, inv-normal transformed) | GCST90476341 | 1.69 |
| 4751 | ITGBL1 levels | GCST90469648 | 1.69 |
| 4752 | CD300LG/CLEC14A ratio | GCST90313801 | 1.69 |
| 4753 | SNAP29 levels | GCST90470692 | 1.69 |
| 4754 | CD163/DSC2 ratio | GCST90313733 | 1.68 |
| 4755 | Main speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000419 | 1.68 |
| 4756 | Concentration of IDL particles | GCST90497606 | 1.68 |
| 4757 | IDP dMRI ProbtrackX L1 str l | GCST90004269 | 1.68 |
| 4758 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 1.68 |
| 4759 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 1.68 |
| 4760 | Treatment/medication code - simvastatin | Medications | UKBB00000859 | 1.68 |
| 4761 | Total esterified cholesterol levels (UKB data field 23415) | GCST90269512 | 1.68 |
| 4762 | Retinal breaks without detachment | FING00001258 | 1.68 |
| 4763 | PNLIPRP1 levels | GCST90470273 | 1.68 |
| 4764 | Delta body mass index (difference between ECG-predicted and measured) | GCST90429062 | 1.68 |
| 4765 | CDH5/ENG ratio | GCST90313954 | 1.68 |
| 4766 | BCAM/CLEC14A ratio | GCST90313470 | 1.68 |
| 4767 | aparc-a2009s rh volume G+S-subcentral | GCST90003002 | 1.68 |
| 4768 | MANF levels | GCST90469846 | 1.68 |
| 4769 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119 | ECGU000119 | 1.68 |
| 4770 | NTRK3/SCARF2 ratio | GCST90315571 | 1.68 |
| 4771 | IGSF8 levels | GCST90469540 | 1.67 |
| 4772 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T278 | ECGA000278 | 1.67 |
| 4773 | Principal component-derived dietary pattern 5 | GCST90133010 | 1.67 |
| 4774 | IDP dMRI ProbtrackX ICVF atr r | GCST90004378 | 1.67 |
| 4775 | Total protein levels | GCST90018756 | 1.67 |
| 4776 | Ulcerative colitis | GCST90475322 | 1.67 |
| 4777 | CLEC14A/PTPRS ratio | GCST90314081 | 1.67 |
| 4778 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180 | ECGA000180 | 1.67 |
| 4779 | VWC2 levels | GCST90471064 | 1.67 |
| 4780 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T316 | ECGA000316 | 1.67 |
| 4781 | Diastolic blood pressure x sex interaction | GCST90335175 | 1.67 |
| 4782 | PDGFB/TNFSF13 ratio | GCST90315632 | 1.66 |
| 4783 | Total esterified cholesterol levels | GCST90500036 | 1.66 |
| 4784 | TXN levels | GCST90470995 | 1.66 |
| 4785 | 21-hydroxypregnenolone disulfate levels | GCST90199849 | 1.66 |
| 4786 | Hearing aid use | GCST90044774 | 1.66 |
| 4787 | OLR1/OSM ratio | GCST90315583 | 1.66 |
| 4788 | Volume of left paralaminar nucleus | GCST90474985 | 1.66 |
| 4789 | Hippocampal right HATA volume | GCST90267969 | 1.66 |
| 4790 | Gestational thrombocytopenia | GCST90302234 | 1.66 |
| 4791 | CXCL12 levels | GCST90468925 | 1.66 |
| 4792 | BLVRB/CA2 ratio | GCST90313522 | 1.66 |
| 4793 | Haematocrit percentage | Blood count | UKBB00000292 | 1.66 |
| 4794 | CD248 levels | GCST90468612 | 1.66 |
| 4795 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 1.66 |
| 4796 | ENO2/SCRN1 ratio | GCST90314668 | 1.66 |
| 4797 | CLEC1B/MGLL ratio | GCST90314097 | 1.66 |
| 4798 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T252 | ECGA000252 | 1.65 |
| 4799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T310 | ECGA000310 | 1.65 |
| 4800 | Inguinal hernia | digestive | UKBB00000362 | 1.65 |
| 4801 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 1.65 |
| 4802 | AXIN1/BACH1 ratio | GCST90313400 | 1.65 |
| 4803 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 1.65 |
| 4804 | Chronic myeloproliferative disease | FING00000294 | 1.65 |
| 4805 | NSFL1C/RILP ratio | GCST90315560 | 1.65 |
| 4806 | DSG3 levels | GCST90469043 | 1.65 |
| 4807 | Major depressive disorder (probable) | GCST005904 | 1.65 |
| 4808 | Omega-3 fatty acids to total fatty acids percentage | GCST90502467 | 1.65 |
| 4809 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T324 | ECGA000324 | 1.64 |
| 4810 | Educational attainment | GCST002598 | 1.64 |
| 4811 | REG1A/REG3A ratio | GCST90315761 | 1.64 |
| 4812 | IRAK4/VASH1 ratio | GCST90315201 | 1.64 |
| 4813 | GATD3 levels | GCST90469309 | 1.64 |
| 4814 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280 | ECGA000280 | 1.64 |
| 4815 | CXCL3/MGLL ratio | GCST90314345 | 1.64 |
| 4816 | Pain type(s) experienced in last month - Back pain | Pain | UKBB00000626 | 1.64 |
| 4817 | Corneal edema (PheCode 364.2) | GCST90475862 | 1.64 |
| 4818 | Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302722 | 1.64 |
| 4819 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T322 | ECGU000322 | 1.63 |
| 4820 | ICAM5 levels | GCST90469502 | 1.63 |
| 4821 | Other dyspnea (PheCode 512.9) | GCST90476042 | 1.63 |
| 4822 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T197 | ECGU000197 | 1.63 |
| 4823 | PDGFRB levels | GCST90470192 | 1.63 |
| 4824 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T343 | ECGU000343 | 1.63 |
| 4825 | Paraproteinemia (PheCode 270.32) | GCST90475710 | 1.63 |
| 4826 | CST3/CTSZ ratio | GCST90314290 | 1.63 |
| 4827 | ACOX1/VSIR ratio | GCST90313155 | 1.63 |
| 4828 | SULT1A1 levels | GCST90470781 | 1.63 |
| 4829 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402) | GCST90269499 | 1.63 |
| 4830 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 1.62 |
| 4831 | HSPG2 levels | GCST90469491 | 1.62 |
| 4832 | VSIG10 levels | GCST90471050 | 1.62 |
| 4833 | Hip circumference (UKB data field 49) | GCST90468170 | 1.62 |
| 4834 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000387 | 1.62 |
| 4835 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 1.62 |
| 4836 | KEL levels | GCST90469673 | 1.62 |
| 4837 | BCAN/MOG ratio | GCST90313480 | 1.62 |
| 4838 | CERT/MAX ratio | GCST90314028 | 1.62 |
| 4839 | ALPP/MSLN ratio | GCST90313250 | 1.62 |
| 4840 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 1.62 |
| 4841 | CST6/FABP9 ratio | GCST90314301 | 1.62 |
| 4842 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T241 | ECGA000241 | 1.61 |
| 4843 | Frequency of heavy DIY in last 4 weeks | Physical activity | UKBB00000263 | 1.61 |
| 4844 | KL levels | GCST90091246 | 1.61 |
| 4845 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502051 | 1.61 |
| 4846 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 1.61 |
| 4847 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247 | ECGA000247 | 1.61 |
| 4848 | Frozen shoulder | GCST90000513 | 1.61 |
| 4849 | Hair colour (natural, before greying) - Dark brown | Sun exposure | UKBB00000297 | 1.61 |
| 4850 | CX3CL1/PODXL2 ratio | GCST90314326 | 1.61 |
| 4851 | CDH5/NOTCH1 ratio | GCST90313957 | 1.61 |
| 4852 | Congestive heart failure (CHF) NOS (PheCode 428.1) | GCST90475982 | 1.61 |
| 4853 | ICAM2 levels | GCST90469499 | 1.61 |
| 4854 | CXCL10/WARS ratio | GCST90314332 | 1.61 |
| 4855 | Multiple myeloma | GCST90624747 | 1.61 |
| 4856 | Attendance/disability/mobility allowance - None of the above | Other sociodemographic factors | UKBB00000059 | 1.61 |
| 4857 | CR1 levels | GCST90468851 | 1.61 |
| 4858 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T315 | ECGA000315 | 1.61 |
| 4859 | IDP dMRI TBSS L1 Superior corona radiata R | GCST90004099 | 1.61 |
| 4860 | Cystitis | FING00000376 | 1.61 |
| 4861 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90092943 | 1.60 |
| 4862 | PDGFA/SPARC ratio | GCST90315620 | 1.60 |
| 4863 | Heart rate variability (corrected standard deviation of normal-to-normal intervals) | GCST90281266 | 1.60 |
| 4864 | Dissection of aorta | FING00000467 | 1.60 |
| 4865 | aparc-a2009s lh thickness S-intrapariet+P-trans | GCST90003658 | 1.60 |
| 4866 | VAMP5 levels | GCST90471024 | 1.60 |
| 4867 | Forced expiratory volume (baseline) | GCST90565844 | 1.60 |
| 4868 | Autoimmune polyglandular failure | FING00000135 | 1.60 |
| 4869 | Body mass index | GCST90428119 | 1.60 |
| 4870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151 | ECGU000151 | 1.60 |
| 4871 | ICD10 N87: Dysplasia of cervix uteri | GCST90454218 | 1.60 |
| 4872 | BPIFB1 levels | GCST90468462 | 1.60 |
| 4873 | Idiopathic pulmonary fibrosis | GCST90399720 | 1.59 |
| 4874 | IDP dMRI ProbtrackX ICVF unc l | GCST90004400 | 1.59 |
| 4875 | HippSubfield lh volume CA4-head | GCST90002682 | 1.59 |
| 4876 | CXCL8 levels | GCST90468934 | 1.59 |
| 4877 | CLPS/PRSS2 ratio | GCST90314141 | 1.59 |
| 4878 | ANKMY2 levels | GCST90468309 | 1.59 |
| 4879 | PDGFB/ST6GAL1 ratio | GCST90315630 | 1.59 |
| 4880 | IDP T1 SIENAX brain-normalised volume | GCST90002434 | 1.59 |
| 4881 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T112 | ECGA000112 | 1.59 |
| 4882 | Cylindrical power (right) | Autorefraction | UKBB00000162 | 1.59 |
| 4883 | CCL17/THPO ratio | GCST90313689 | 1.59 |
| 4884 | DTI TBSS L3 Sagittal stratum R | GCST90384554 | 1.59 |
| 4885 | EBAG9/MITD1 ratio | GCST90314566 | 1.59 |
| 4886 | REST UKBBICA NODEamps25 0005 | GCST90385488 | 1.59 |
| 4887 | Left-hemisphere control network to amygdala white-matter structural connectivity | GCST90302757 | 1.59 |
| 4888 | GRAP2/SRC ratio | GCST90314989 | 1.58 |
| 4889 | Oral glucose tolerance test-0h | GCST90297788 | 1.58 |
| 4890 | Omega-6 fatty acid levels | GCST90092933 | 1.58 |
| 4891 | Other specified diseases of sebaceous glands (PheCode 706.8) | GCST90476215 | 1.58 |
| 4892 | DECR1 levels | GCST90468978 | 1.58 |
| 4893 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475354 | 1.58 |
| 4894 | Medication use (salicylic acid and derivatives) | GCST90018775 | 1.58 |
| 4895 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T312 | ECGA000312 | 1.58 |
| 4896 | rfMRI connectivity (ICA100 edge 380) | GCST90005233 | 1.57 |
| 4897 | Arm fat mass (left) | Impedance measures | UKBB00000043 | 1.57 |
| 4898 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2 | ECGA000002 | 1.57 |
| 4899 | DTI TBSS L2 Superior longitudinal fasciculus R | GCST90384516 | 1.57 |
| 4900 | OLFM4 levels | GCST90470121 | 1.57 |
| 4901 | Special factor anxiety/tension in mitochondrial haplogroup U | GCST90264127 | 1.57 |
| 4902 | AOC3/ITGB1 ratio | GCST90313295 | 1.57 |
| 4903 | aparc-pial lh area precentral | GCST90003164 | 1.57 |
| 4904 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 1.57 |
| 4905 | LYVE1 levels | GCST90469832 | 1.57 |
| 4906 | Spread type: Any oil based spread vs never use spread (UKB data field 1428) | GCST90132949 | 1.57 |
| 4907 | PDLIM5 levels | GCST90470197 | 1.57 |
| 4908 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000182 | 1.57 |
| 4909 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T330 | ECGU000330 | 1.57 |
| 4910 | CD40/ITGB5 ratio | GCST90313816 | 1.57 |
| 4911 | USO1 levels | GCST90471018 | 1.56 |
| 4912 | IDP dMRI ProbtrackX L1 unc r | GCST90004272 | 1.56 |
| 4913 | Major coronary heart disease event | FING00000746 | 1.56 |
| 4914 | Linoleic acid to total fatty acids percentage | GCST90502337 | 1.56 |
| 4915 | IDP dMRI TBSS OD Posterior corona radiata R | GCST90004428 | 1.56 |
| 4916 | GPR15L levels | GCST90469396 | 1.56 |
| 4917 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468 | ECGU000468 | 1.56 |
| 4918 | CFD levels | GCST90468725 | 1.56 |
| 4919 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395 | ECGA000395 | 1.56 |
| 4920 | IDP dMRI ProbtrackX L3 ilf r | GCST90004315 | 1.56 |
| 4921 | Cholesteryl esters in medium VLDL (UKB data field 23506) | GCST90269603 | 1.56 |
| 4922 | IL1R1 levels | GCST90469571 | 1.55 |
| 4923 | NFKB1 levels | GCST90470037 | 1.55 |
| 4924 | AXL/VCAM1 ratio | GCST90313423 | 1.55 |
| 4925 | Cardiac defibrillator in situ (PheCode 426.92) | GCST90475961 | 1.55 |
| 4926 | ATG16L1 levels | GCST90468383 | 1.55 |
| 4927 | Principal component-derived dietary pattern 39 | GCST90133044 | 1.55 |
| 4928 | red blood cell count (RBC, minimum, inv-norm transformed) | GCST90476353 | 1.55 |
| 4929 | Total cholesterol levels | GCST90092985 | 1.55 |
| 4930 | IDP dMRI ProbtrackX OD fma | GCST90004460 | 1.55 |
| 4931 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 1.55 |
| 4932 | Alanine transaminase (ALT, maximum, inv-norm transformed) | GCST90475109 | 1.55 |
| 4933 | Bone marrow fat fraction of right proximal femur | GCST90652393 | 1.55 |
| 4934 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396 | ECGA000396 | 1.55 |
| 4935 | Red blood cell count | GCST90278641 | 1.55 |
| 4936 | UFD1 levels | GCST90471005 | 1.55 |
| 4937 | Glutamine levels | GCST90497285 | 1.55 |
| 4938 | PTPRH levels | GCST90470382 | 1.55 |
| 4939 | Hearing difficulty/problems | Hearing | UKBB00000311 | 1.54 |
| 4940 | HippSubfield rh volume CA4-body | GCST90002705 | 1.54 |
| 4941 | F-caffeinated/sweet liking (derived food-liking factor) | GCST90094720 | 1.54 |
| 4942 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462 | ECGU000462 | 1.54 |
| 4943 | ANPEP levels | GCST90468313 | 1.54 |
| 4944 | Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302714 | 1.54 |
| 4945 | CD209/GP2 ratio | GCST90313751 | 1.54 |
| 4946 | X-24337 levels | GCST90200629 | 1.54 |
| 4947 | Illnesses of father - Lung cancer | Family history | UKBB00000344 | 1.54 |
| 4948 | EREG/F2R ratio | GCST90314700 | 1.53 |
| 4949 | IDP dMRI ProbtrackX L1 str r | GCST90004270 | 1.53 |
| 4950 | Cervical cancer | GCST90018597 | 1.53 |
| 4951 | LILRA5 levels | GCST90469774 | 1.53 |
| 4952 | DLK1/RGMB ratio | GCST90314493 | 1.53 |
| 4953 | Hearing difficulty/problems with background noise | Hearing | UKBB00000312 | 1.53 |
| 4954 | CD99/MMP3 ratio | GCST90313928 | 1.53 |
| 4955 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T65 | ECGU000065 | 1.53 |
| 4956 | WAS levels | GCST90471071 | 1.52 |
| 4957 | CALCOCO1/PFKFB2 ratio | GCST90313608 | 1.52 |
| 4958 | Left-hemisphere visual network to thalamus white-matter structural connectivity | GCST90302662 | 1.52 |
| 4959 | Alcohol usually taken with meals | Alcohol | UKBB00000025 | 1.52 |
| 4960 | aparc-a2009s rh area S-oc-temp-med+Lingual | GCST90003431 | 1.52 |
| 4961 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | GCST90004370 | 1.52 |
| 4962 | Mean corpuscular volume | Blood count | UKBB00000449 | 1.52 |
| 4963 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T192 | ECGU000192 | 1.52 |
| 4964 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T245 | ECGA000245 | 1.52 |
| 4965 | DTI autoptx MD unc l tract | GCST90385245 | 1.52 |
| 4966 | FKBP4/WWP2 ratio | GCST90314842 | 1.52 |
| 4967 | DTI autoptx L3 unc l tract | GCST90385218 | 1.52 |
| 4968 | Strenuous sports or other exercises | GCST006100 | 1.52 |
| 4969 | Left ventricular end systole inferolateral wall thickness | GCST90278510 | 1.52 |
| 4970 | CALCOCO2 levels | GCST90468531 | 1.51 |
| 4971 | wg lh intensity-contrast rostralanteriorcingulate | GCST90003817 | 1.51 |
| 4972 | AIFM1 levels | GCST90468268 | 1.51 |
| 4973 | Moderate to vigorous physical activity levels | GCST006097 | 1.51 |
| 4974 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240 | ECGA000240 | 1.51 |
| 4975 | CCL15/CCL23 ratio | GCST90313681 | 1.51 |
| 4976 | CEACAM1 levels | GCST90468692 | 1.51 |
| 4977 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397 | ECGA000397 | 1.51 |
| 4978 | IDP dMRI TBSS L1 Posterior corona radiata R | GCST90004101 | 1.51 |
| 4979 | Omega-3 fatty acid levels | GCST90502440 | 1.50 |
| 4980 | AXL/CD163 ratio | GCST90313418 | 1.50 |
| 4981 | DUT levels | GCST90469054 | 1.50 |
| 4982 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 1.50 |
| 4983 | Pain (limb, back, neck, head abdominally) | FING00001135 | 1.50 |
| 4984 | Height (weighted GWA) | GCST90267285 | 1.50 |
| 4985 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98 | ECGU000098 | 1.50 |
| 4986 | Creatinine levels | GCST90132719 | 1.50 |
| 4987 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 1.50 |
| 4988 | Suffer from 'nerves' | Mental health | UKBB00000799 | 1.49 |
| 4989 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 1.49 |
| 4990 | Word interpolation | Fluid intelligence / reasoning | UKBB00000918 | 1.49 |
| 4991 | Right-hemisphere visual network to pallidum white-matter structural connectivity | GCST90302784 | 1.49 |
| 4992 | DTI TBSS L3 Anterior corona radiata L | GCST90384547 | 1.49 |
| 4993 | Types of transport used (excluding work) - Car/motor vehicle | Physical activity | UKBB00000876 | 1.49 |
| 4994 | SUOX levels | GCST90470785 | 1.49 |
| 4995 | Stenosis and insufficiency of lacrimal passages | FING00001334 | 1.49 |
| 4996 | IDP SWI T2star right thalamus | GCST90003864 | 1.48 |
| 4997 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185 | ECGA000185 | 1.48 |
| 4998 | Docosahexaenoic acid levels | GCST90502258 | 1.48 |
| 4999 | ADH4/RBP5 ratio | GCST90313194 | 1.48 |
| 5000 | CFHR2 levels | GCST90468726 | 1.48 |